Showing results (231-240 of 260) with videos related to
Sort By:
Pageof 26
Journal for Immunotherapy of Cancer|August 3, 2023
Dysthyroidism during immune checkpoint inhibitors is associated with improved overall survival in adult cancers: data mining of 1385 electronic patient recordsMathilde Beaufils, Vincent Amodru, Manuel Tejeda, et al.Nature Communications|January 25, 2020
Resistance of melanoma to immune checkpoint inhibitors is overcome by targeting the sphingosine kinase-1Caroline Imbert, Anne Montfort, Marine Fraisse, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2007
CD8+ CD28- T regulatory lymphocytes inhibiting T cell proliferative and cytotoxic functions infiltrate human cancersGilberto Filaci, Daniela Fenoglio, Marco Fravega, et al.Cancer Immunology Research|January 31, 2025
Tertiary Lymphoid Structures Are Associated with Enhanced Macrophage Activation and Immune Checkpoint Expression and Predict Outcome in Cervical CancerLaurent Gorvel, Marylou Panouillot, Marie-Sarah Rouvière, et al.Oncoimmunology|December 7, 2017
NKp46 expression on NK cells as a prognostic and predictive biomarker for response to allo-SCT in patients with AMLAnne-Sophie Chretien, Raynier Devillier, Cyril Fauriat, et al.Frontiers in Oncology|October 10, 2022
Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer?Daniele Fanale, Lidia Rita Corsini, Chiara Brando, et al.Cancer Research|February 27, 2009
Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcomeMichael Gobert, Isabelle Treilleux, Nathalie Bendriss-Vermare, et al.Blood Advances|October 23, 2020
ICOS is widely expressed in cutaneous T-cell lymphoma, and its targeting promotes potent killing of malignant cellsFlorent Amatore, Nicolas Ortonne, Marc Lopez, et al.Oncotarget|September 20, 2019
Correction: NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemiaAnne-Sophie Chretien, Cyril Fauriat, Florence Orlanducci, et al.Human Pathology|April 18, 2017
Rituximab treatment circumvents the prognostic impact of tumor-infiltrating T-cells in follicular lymphoma patientsLuc Xerri, Sarah Huet, Jeffrey M Venstrom, et al.Pageof 26